Posts Tagged ‘inv:BC-Advantage-Funds’
Aquinox Pharmaceuticals, a Vancouver drug developer, raised $14.5 million in a first funding round. Ventures West Capital led the round, joined by Johnson & Johnson Development Corp., Baker Brothers Investments and BC Advantage Funds.
Aquinox is developing drugs that inhibit a newly discovered enzyme called SHIP (for more detail, see here) that appears to play an important role in blood cancers and inflammatory diseases. The company’s lead drug candidate, AQX-MN100, is still in animal testing.
Top Stories
- Nanosolar outshines the competition with a $300M ...
- Spotted: FriendFeed Beta -- coming soon
- iPhone app developers report to OpenClip.org immediately. ...
- Fanboys unite: Google and Apple trounce rivals ...
- A first look at the Google Android ...
Featured Guest Columnists
- David Gal
Is Facebookâs Platform a strategic mistake? - Richard Wong
View from Barcelona: The end of the operator-dominated era? - Bernard Moon
U.S. tech trends for 2008
Job Board
- Interactive Production Designer
at EyeWonder, Inc (233 Peachtree Street Atlanta, GA 30303) - Alliance Marketing Consultant BP
at Sun Microsystems (MENLO PARK, CA) - Alliance Marketing
at Sun Microsystems (MENLO PARK, CA) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- David Hamilton, Editor, LifeScience
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress